发明名称 Monoclinic crystalline form of asenapine maleate with a specific particle size distribution
摘要 A monoclinic crystalline form of asenapine maleate is described, which is characterized in that it is not micronised and has a particle size distribution characterized by a d90 of 40 μm or less. A process for the preparation of a monoclinic crystalline form of asenapine maleate is also described, the process comprising the following steps: a) providing a mixture of monoclinic asenapine maleate and an organic solvent which, under the conditions of the process, acts as an antisolvent; b) stirring the mixture at a temperature between 15 and 60° C.; and c) collecting the crystals, wherein the organic solvent is selected from alcohols, ketones, ethers, esters, hydrocarbons or mixtures thereof.
申请公布号 US9533994(B2) 申请公布日期 2017.01.03
申请号 US201214118483 申请日期 2012.05.18
申请人 Laboratorios Lesvi S.L. 发明人 Solà Carandell Lluis;Cerón Bertran Jordi;Freixas Pascual Glòria;Dalmases Pere
分类号 C07D491/04;C07D491/044;A61K31/407 主分类号 C07D491/04
代理机构 Stites & Harbison, PLLC 代理人 Stites & Harbison, PLLC ;Wright Terry L.
主权项 1. A monoclinic crystalline form of asenapine maleate characterized in that it is not micronized, has a polymorphic purity of more than 90%, and has a particle size distribution characterized by a d90 of 31 μm or less, preferably of 16 μm or less.
地址 Barcelona ES